Characterization of adult stem/progenitor cell populations from bone marrow in a three-dimensional collagen gel culture system

Cell Transplantation

Volumn 21, Issue 9, 2012, Pages 2021-2032

  Claros, Silvia ^a   Rodríguez Losada, Noela ^b   Cruz, Encarnación ^c   Guerado, Enrique ^c   Becerra, José ^a   Andrades, José A ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Demineralized bone matrix; Osteogenesis; Stem progenitor cells; Three dimensional (3D) culture; Transforming growth factor b1 (TGF b1)

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; BETA1 INTEGRIN; CD133 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 1; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

ADULT STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; BONE DEVELOPMENT; BONE MATRIX; BONE TISSUE; CARTILAGE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL EXPANSION; TISSUE ENGINEERING;

ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COLLAGEN; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, INBRED F344; STEM CELLS;

RATTUS;

EID: 84869756343     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X636939     Document Type: Article

References (57)

1. + progenitors for the repair of infarcted myocardium. J. Am. Coll. Cardiol. 44:458-463; 2004.
2. Amrani, D. L.; Port, S. Cardiovascular disease: Potential impact of stem cell therapy. Expert Rev. Cardiovasc. Ther. 1:453-461; 2003.
3. Andrades, J. A.; Han, B.; Becerra, J.; Sorgente, N.; Hall, F. L.; Nimni, M. E. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration; growth; and differentiation of bone marrow mesenchymal cells. Exp. Cell Res. 250(2):485-498; 1999.
4. Andrades, J. A.; Han, B.; Nimni, M. E.; Ertl, D. C.; Simpkins, R. J.; Arrabal, M. P.; Becerra, J. A modified rhTGF-beta1 and rhBMP-2 are effective in initiating a chondro-osseous differentiation pathway in bone marrow cells cultured in vitro. Connect. Tissue Res. 44(3-4):188-197; 2003.
5. Andrades, J. A.; Santamaría, J. A.; Nimni, M. E.; Becerra, J. Selection and amplification of a bone marrow cell population and its induction to the chondro-osteogenic lineage by rhOP-1: An in vitro and in vivo study. Int. J. Dev. Biol. 45(4):689-693; 2001.
6. Arthur, A.; Zannettino, A.; Gronthos, S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218(2):237-245; 2009.
7. Asahara, T.; Kawamoto, A. Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 287(3):C572-579; 2004.
8. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967; 1997.
9. Baksh, D.; Zandstra, P. W.; Davies, J. E. A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells. Biotechnol. Bioeng. 98(6):1195-1208; 2007.
10. Becerra, J.; Guerado, E.; Claros, S.; Alonso, M.; Bertrand, M. L.; González, C.; Andrades, J. A. Autologous humanderived bone marrow cells exposed to a novel TGF-beta1 fusion protein for the treatment of critically sized tibial defect. Regen. Med. 1(2):267-278; 2006.
11. Beyer, N.; Da Silva, L. Mesenchymal stem cells: Isolation in vitro expansion and characterization. Handb. Exp. Pharmacol. 174:249-282; 2006.
12. Bianco, P.; Cancedda, F. D.; Riminucci, M.; Cancedda, R. Bone formation via cartilage models: The "borderline" chondrocyte. Matrix Biol. 17(3):185-192; 1998.
13. Bianco, P.; Riminucci, M.; Gronthos, S.; Robey, P. Bone marrow stromal cells: Nature, biology, and potential applications. Stem Cells 19:180-192; 2001.
14. Bruder, S. P.; Ricalton, N. S.; Boynton, R. E.; Connolly, T. J.; Jaiswal, N.; Zaia, J.; Barry, F. P. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J. Bone Miner. Res. 13:655-663; 1998.
15. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98(5):1076-1084; 2006.
16. Chambers, I.; Colby, D.; Robertson, M.; Nichols, J.; Lee, S.; Tweedie, S.; Smith, A. Functional expression cloning of Nanog; a pluripotency sustaining factor in embryonic stem cells. Cell 113(5):643-655; 2003.
17. Conget, P. A.; Allers, C.; Minguell, J. J. Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors. J. Hematother. Stem Cell Res. 10(6):749-758; 2001.
18. Crisan, M.; Yap, S.; Casteilla, L.; Chen, C. W.; Corselli, M.; Park, T. S.; Andriolo, G.; Sun, B.; Zheng, B.; Zhang, L.; Norotte, C.; Teng, P. N.; Traas, J.; Schugar, R.; Deasy, B. M.; Badylak, S.; Buhring, H. J.; Giacobino, J. P.; Lazzari, L.; Huard, J.; Péault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301-313; 2008.
19. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28:875-884; 2000.
20. + marrow cell population is multipotential. Cells Tissues Organs 170:73-82; 2002.
21. D'Ippolito, G.; Diabira, S.; Howard, G. A.; Menei, P.; Roos, B. A.; Schiller, P. C. Marrow-isolated adult multilineage inducible (MIAMI) cells; a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117:2971-2981; 2004.
22. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D. J.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
23. Folgiero, V.; Migliano, E.; Tedesco, M.; Iacovelli, S.; Bon, G.; Torre, M. L.; Sacchi, A.; Marazzi, M.; Bucher, S.; Falcioni, R. Purification and characterization of adiposederived stem cells from patients with lipoaspirate transplant. Cell Transplant. 19(10):1225-1235; 2010.
24. Fricke, S.; Fricke, C.; Oelkrug, C.; Hilger, N.; Schönfelder, U.; Kamprad, M.; Lehmann, J.; Boltze, J.; Emmrich, F.; Sack, U. Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesis. Cell. Mol. Life Sci. 67(23):4095-4106; 2010.
25. Goodell, M. A.; Brose, K.; Paradis, G.; Conner, A. S.; Mulligan, R. C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806; 1996.
26. Gronthos, S.; Zannettino, A. C.; Hay, S. J.; Shi, S.; Graves, S. E.; Kortesidis, A.; Simmons, P. J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 116:1827-1835; 2003.
27. Ishikawa, M.; Asahara, T. Endothelial progenitor cell culture for vascular regeneration. Stem Cells Dev. 13(4):344-349; 2004.
28. Isner, J. M.; Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103(9):1231-1236; 1999.
29. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-González, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49; 2002.
30. Kolf, C. M.; Cho, E.; Tuan, R. S. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 9(1):204; 2007.
31. Krinner, A.; Hoffmann, M.; Loeffler, M.; Drasdo, D.; Galle, J. Individual fates of mesenchymal stem cells in vitro. BMC Syst. Biol. 4:73; 2010.
32. + stem cells identified in adult bone marrow. Leukemia 20(5):857-869; 2006.
33. Li, R.; Stewart, D. J.; von Schroeder, H. P.; Mackinnon, E. S.; Schemitsch, E. H. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J. Orthop. Res. 27:8-14; 2009.
34. Matsumoto, T.; Kuroda, R.; Mifune, Y.; Kawamoto, A.; Shoji, T.; Miwa, M.; Asahara, T.; Kurosaka, M. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone 43:434-439; 2008.
35. Minguell, J. J.; Fierro, F. A.; Epuñan, M. J.; Erices, A. A.; Sierralta, W. D. Nonstimulated human uncommitted mesenchymal stem cells express cell markers of mesenchymal and neural lineages. Stem Cells Dev. 14(4):408-414; 2005.
36. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5):631-642; 2003.
37. Nimni, M. E.; Bernick, S.; Ertl, D. L.; Nishimoto, S. K.; Paule, W.; Strates, B. S.; Villanueva, J. Ectopic bone formation is enhanced in senescent animals implanted with embryonic cells. Clin. Orthop. 234:255-266; 1988.
38. Peichev, M.; Naiyer, A. J.; Pereira, D.; Zhu, Z.; Lane, W. J.; Williams, M.; Oz, M. C.; Hicklin, D. J.; Witte, L.; Moore, M. A.; Rafii, S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958; 2000.
39. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
40. Rafii, S.; Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9(6):702-712; 2003.
41. Rafii, S.; Lyden, D.; Benezra, R.; Hattori, K.; Heissig, B. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2(11):826-835; 2002.
42. Rasmusson, I. Immune modulation by mesenchymal stem cells. Exp. Cell Res. 312:2169-2179; 2006.
43. Rodda, D. J.; Chew, J. L.; Lim, L. H.; Loh, Y. H.; Wang, B.; Ng, H. H.; Robson, P. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280(26):24731-24737; 2005.
44. Scotti, C.; Tonnarelli, B.; Papadimitropoulos, A.; Scherberich, A.; Schaeren, S.; Schauerte, A.; Lopez-Rios, J.; Zeller, R.; Barbero, A.; Martin, I. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc. Natl. Acad. Sci. USA 107(16):7251-7256; 2010.
45. Serafini, M.; Verfaillie, C. M. Multipotent progenitor cell populations obtained from bone marrow. In: Garcia-Olmo, D.; Garcia-Verdugo, J. M., eds. Cell Therapy. Maidenhead, UK: McGraw Hill; 2008:89-102.
46. Shi, Q.; Rafii, S.; Wu, M. H.; Wijelath, E. S.; Yu, C.; Ishida, A.; Fujita, Y.; Kothari, S.; Mohle, R.; Sauvage, L. R.; Moore, M. A.; Storb, R. F.; Hammond, W. P. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367; 1998.
47. Smadja, D. M.; Mauge, L.; Sanchez, O.; Silvestre, J. S.47.; Guerin, C.; Godier, A.; Henno, P.; Gaussem, P.; Israël-Biet, D. Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur. Respir. J. 36(6):1284-1293; 2010.
48. Solovey, A. N.; Gui, L.; Chang, L.; Enenstein, J.; Browne, P. V.; Hebbel, R. P. Identification and functional assessment of endothelial P1H12. J. Lab. Clin. Med. 138(5):322-331; 2001.
49. Stamm, C.; Westphal, B.; Kleine, H. D.; Petzsch, M.; Kittner, C.; Klinge, H.; Schümichen, C.; Nienaber, C. A.; Freund, M.; Steinhoff, G. Autologous bone-marrow stemcell transplantation for myocardial regeneration. Lancet 361:45-46; 2003.
50. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676; 2006.
51. Tondreau, T.; Meuleman, N.; Delforge, A.; Dejeneffe, M.; Leroy, R.; Massy, M.; Mortier, C.; Bron, D.; Lagneaux, L. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. Stem Cells 23(8):1105-1112; 2005.
52. -circulating endothelial precursor cells (CEP): Characterization; senescence and in vivo application. Exp. Gerontol. 41(6):600-608; 2006.
53. van den Bos, T.; Speijer, D.; Bank, R. A.; Brömme, D.; Everts, V. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen. Bone 43(3):459-468; 2008.
54. Włodarski, K. H.; Galus, R.; Włodarski, P. Non-adherent bone marrow cells are a rich source of cells forming bone in vivo. Folia Biol. (Praha) 50:167-173; 2004.
55. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920; 2007.
56. Zhao, H. X.; Li, Y.; Jin, H. F.; Xie, L.; Liu, C.; Jiang, F.; Luo, Y. N.; Yin, G. W.; Li, Y.; Wang. J.; Li, L. S.; Yao, Y. Q.; Wang, X. H. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Differentiation 80(2-3): 123-129; 2010.
57. Zheng, C.; Yang, S.; Guo, Z.; Liao, W.; Zhang, L.; Yang, R.; Han, Z. C. Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers. Cell Transplant. 18(10):1093-1109; 2009.